Cargando…
Dose Escalation of Vitamin D(3) Yields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model
Vitamin D(3) (VD(3)) is an effective adjunctive agent, enhancing the destructive effects of freezing in prostate cancer cryoablation studies. We investigated whether dose escalation of VD(3) over several weeks, to model the increase in physiological VD(3) levels if an oral supplement were prescribed...
Autores principales: | Santucci, Kimberly L., Baust, John M., Snyder, Kristi K., Van Buskirk, Robert G., Baust, John G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933822/ https://www.ncbi.nlm.nih.gov/pubmed/29480024 http://dx.doi.org/10.1177/1073274818757418 |
Ejemplares similares
-
Assessment of Cryosurgical Device Performance Using a 3D Tissue-Engineered Cancer Model
por: Baust, John M., et al.
Publicado: (2017) -
The use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model
por: Santucci, Kimberly L., et al.
Publicado: (2011) -
Investigation of Bladder Cancer Cell Response to Cryoablation and Adjunctive Cisplatin Based Cryo/Chemotherapy
por: Santucci, Kimberly L, et al.
Publicado: (2020) -
Defeating Cancers’ Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer’s Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome
por: Baust, John M., et al.
Publicado: (2018) -
An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line
por: Baust, John M., et al.
Publicado: (2022)